Heterogeneous nuclear ribonucleoprotein A2B1, a novel drug target for hepatitis B virus infection

Min Xu(Nanjing Agricultural University), Daming Zuo(Anhui Medical University)
Research Square
April 16, 2021
Cited by 0


Related Papers